Nigel Foulkes is the Managing Director at Ginger Pharma (Jan 2014 - Present), a tailored market access and new product launch consultancy specialising in niche and orphan drugs, especially in the oncology and haematology sector, including biosimilars and generics. Also experienced in ophthalmology, diabetes, cardiovascular, neurology and OTC medicines. He has knowledge and experience of global pricing and reimbursement issues. Prior to this, Nigel was the Strategy Lead at AbbVie (July 2017 - Oct 2020), specialising in Government Affairs, Market Access & Reimbursement. He also worked at Roche Diabetes Care, UK & Ireland (Sep 2016 - Jul 2017), working with NHS & HSE Commissioners - Market Access & Government Affairs. He was responsible for market access and marketing across UK/IE. Nigel also worked at Fresenius Biotech, Germany (2011 - 2013) as the Country Manager for UK/IE, responsible for product launches in these regions. Prior to that he was Country Manager for Ratiopharm (2008-2010) and TopoTarget (2006-2008), in both roles launching new and innovative treatments. Extensive biosimilar and generics experience.